MME and lymphoma: CD10, an immunophenotypic marker of B-lymphoblastic leukemia/lymphoma and follicular lymphoma, has been reported to be expressed in 18–63% of cases of T-lymphoblastic leukemia/lymphoma, as well as in other T cell neoplasms [6].